This article considers neuraminidase inhibitors, which are active against influenza virus and are crucial to planning for an influenza pandemic from a new influenza virus of any origin, including a ...

But the possibility of widespread oseltamivir resistance has been a concern for several years. Structural analysis of the influenza neuraminidase predicted that resistance to oseltamivir would be ...

A study published in PLOS PATHOGENS describes the prevalence and functions of mutations in neuraminidase enzyme of avian H5N1 influenza viruses that are preferentially selected in human H5N1 ...

First influenza-specific neuraminidase test kit for flu vaccines InDevR's game-changing VaxArray® vaccine potency testing platform now includes a reagent kit for rapid assessment of neuraminidase ...

InDevR Inc. announced commercial availability of a VaxArray reagent kit for neuraminidase (NA) from influenza viruses containing the N9 subtype. Together with InDevR's VaxArray reagent kit for ...

Complementary Assays Helping to Overcome Challenges for Identifying Neuraminidase Inhibitors ...

A recent study published in Viruses reviewed the characteristics of neuraminidase with emphasis on the development of NA-based universal influenza vaccines.

Randomized multicenter double-blind phase II trial: The immunological adjuvant OPT-821 with or without a trivalent ganglioside vaccine in metastatic sarcoma patients following metastasectomy.